Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v33-EN Version v6-FR
Language English French
Date Updated 2021-12-16 2017-10-17
Drug Identification Number 02326663 02326663
Brand name ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP
Common or Proper name Erythromycin Ophthalmic Ointment USP Erythromycin Ophthalmic Ointment USP
Company Name STERI-MED PHARMA INC. STERI-MED PHARMA INC.
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 5MG 5MG
Dosage form(s) OINTMENT OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 1 g 1 g
ATC code S01AA S01AA
ATC description ANTIINFECTIVES ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-09 2017-03-09
Estimated end date 2021-12-15 2017-11-30
Actual end date 2021-12-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments